Options
Heinemann, Stephanie
Loading...
Preferred name
Heinemann, Stephanie
Official Name
Heinemann, Stephanie
Alternative Name
Heinemann, S.
Main Affiliation
Now showing 1 - 10 of 38
2016-07Journal Article Research Paper [["dc.bibliographiccitation.firstpage","e121"],["dc.bibliographiccitation.issue","13"],["dc.bibliographiccitation.journal","Deutsche medizinische Wochenschrift"],["dc.bibliographiccitation.lastpage","e126"],["dc.bibliographiccitation.volume","141"],["dc.contributor.author","Weiß, V."],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Nau, R."],["dc.contributor.author","Hummers-Pradier, Eva"],["dc.date.accessioned","2021-08-26T13:16:49Z"],["dc.date.available","2021-08-26T13:16:49Z"],["dc.date.issued","2016-07"],["dc.description.abstract","Aim "],["dc.identifier.doi","10.1055/s-0042-102618"],["dc.identifier.pmid","27359319"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88837"],["dc.language.iso","other"],["dc.relation.eissn","1439-4413"],["dc.relation.issn","0012-0472"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Benzodiazepine und Z-Substanzen als Schlaf- und Beruhigungsmittel in einem Krankenhaus"],["dc.title.alternative","The use of benzodiazepines and Z-drugs for patients with sleeping problems - A survey among hospital doctors and nurses"],["dc.title.subtitle","Anwendung aus der Sicht des ärztlichen und pflegerischen Personals"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2020Journal Article Research Paper [["dc.bibliographiccitation.firstpage","394"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Translational Medicine"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Bahls, Thomas"],["dc.contributor.author","Pung, Johannes"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hauswaldt, Johannes"],["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","Blumentritt, Arne"],["dc.contributor.author","Rau, Henriette"],["dc.contributor.author","Drepper, Johannes"],["dc.contributor.author","Wieder, Philipp"],["dc.contributor.author","Groh, Roland"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Schlegelmilch, Falk"],["dc.date.accessioned","2020-10-29T15:25:39Z"],["dc.date.available","2020-10-29T15:25:39Z"],["dc.date.issued","2020"],["dc.description.abstract","Medical data from family doctors are of great importance to health care researchers but seem to be locked in German practices and, thus, are underused in research. The RADAR project (Routine Anonymized Data for Advanced Health Services Research) aims at designing, implementing and piloting a generic research architecture, technical software solutions as well as procedures and workflows to unlock data from family doctor's practices. A long-term medical data repository for research taking legal requirements into account is established. Thereby, RADAR helps closing the gap between the European countries and to contribute data from primary care in Germany."],["dc.identifier.doi","10.1186/s12967-020-02547-x"],["dc.identifier.pmid","33076938"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/17623"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68099"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.relation","RADARplus - Anonymisierte Routinedaten aus der ambulanten Versorgung für die Versorgungsforschung"],["dc.relation.issn","1479-5876"],["dc.relation.orgunit","Institut für Medizinische Informatik"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Designing and piloting a generic research architecture and workflows to unlock German primary care data for secondary use"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2017-12Journal Article Research Paper [["dc.bibliographiccitation.firstpage","905"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","International Journal of Clinical Pharmacology and Therapeutics"],["dc.bibliographiccitation.lastpage","910"],["dc.bibliographiccitation.volume","55"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Himmel, Wolfgang"],["dc.date.accessioned","2021-08-26T14:46:04Z"],["dc.date.available","2021-08-26T14:46:04Z"],["dc.date.issued","2017-12"],["dc.description.abstract","A chart review at a mid-sized German general hospital found a high usage of benzodiazepines among older patients. Therefore, all doctors and nurses of this hospital were surveyed about the benefits and risks of benzodiazepines that they considered to be the strongest and their own overall assessment of the risk-benefit ratio for their patients Response rate was 54% (63/116) for doctors and 30% (73/243) for nurses. \"Reduced fear or agitation\" was perceived by many doctors (71%) and nurses (49%) to be a strong benefit of benzodiazepines. With regards to the overall risk-benefit ratio, doctors who indicated that \"falls\" and/or \"craving\" often occur in combination with benzodiazepines were more likely to estimate that the risks of benzodiazepines outweigh the benefits. For nurses, \"confusion\" strongly influenced their overall assessment of the risk-benefit ratio. The results of this study will be incorporated into interventions for reducing benzodiazepine prescriptions. ."],["dc.identifier.doi","10.5414/CP203104"],["dc.identifier.pmid","29092732"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88877"],["dc.language.iso","en"],["dc.relation.issn","0946-1965"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Searching for factors that may reduce the use of benzodiazepines in hospitals - a survey of hospital doctors and nurses "],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2019Journal Article Research Paper [["dc.bibliographiccitation.firstpage","285"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","European Journal of Clinical Pharmacology"],["dc.bibliographiccitation.lastpage","290"],["dc.bibliographiccitation.volume","76"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Brockmöller, Jürgen"],["dc.contributor.author","Hagmayer, York"],["dc.contributor.author","Himmel, Wolfgang"],["dc.date.accessioned","2020-12-10T14:09:57Z"],["dc.date.available","2020-12-10T14:09:57Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1007/s00228-019-02783-1"],["dc.identifier.eissn","1432-1041"],["dc.identifier.issn","0031-6970"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70614"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","Why Z-drugs are used even if doctors and nurses feel unable to judge their benefits and risks—a hospital survey"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]Details DOI2022Journal Article Research Paper [["dc.bibliographiccitation.firstpage","ejhpharm-2021-003097"],["dc.bibliographiccitation.journal","European Journal of Hospital Pharmacy"],["dc.bibliographiccitation.volume","Online ahead of print"],["dc.contributor.author","Klemperer, Jonas"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Nau, Roland"],["dc.creator.author","Stephanie Heinemann"],["dc.creator.author","Jonas Klemperer"],["dc.creator.author","Eva Hummers"],["dc.creator.author","Roland Nau"],["dc.creator.author","Wolfgang Himmel"],["dc.date.accessioned","2022-11-29T10:10:56Z"],["dc.date.available","2022-11-29T10:10:56Z"],["dc.date.issued","2022"],["dc.description.abstract","Objectives: Many patients receive benzodiazepines or Z-drugs during hospitalisation due to sleeping problems. In a pilot study, we aimed to find out whether, and to what degree, a multi-faceted intervention can reduce the use of these drugs, especially in older patients and those without a psychiatric or neurological disorder. The results of this pilot study should inform the design of a randomised controlled trial (RCT).\r\n\r\nMethods: In a quasi-experimental design, we implemented the intervention in a German hospital with the support of the hospital director, medical and nursing staff and employee representatives. We compared prescription data for sleep-inducing drugs before and after the intervention by Fisher's exact test and used odds ratios (ORs) with their 95% CIs as a measure of effect size.\r\n\r\nResults: The data from 960 patients aged ≥65 years before intervention and 1049 patients after intervention were analysed. Before intervention, 483 (50.3%) of the patients received sleep-inducing drugs at some time during their hospital stay. After the intervention, 381 (36.3%) patients received a sleep-inducing drug, resulting in an OR of 0.56 (95% CI 0.47 to 0.68) (p<0.001). The reduction was particularly pronounced in patients without a psychiatric or neurological disorder (from 45.0% to 28.8%). In particular, the consumption of benzodiazepines declined from 24.3% to 8.5% (OR 0.31; 95% CI 0.23 to 0.4) (p<0.001).\r\n\r\nConclusions: A multi-faceted intervention to change the practice of the use of sleep-inducing drugs in one hospital was successful in terms of drug reduction, particularly for benzodiazepines. The intervention was effective especially for target persons-that is, those without a psychiatric or neurological disease. Awareness of the magnitude of the change and the role of important stakeholders could help researchers and hospital staff to design a large RCT, including control hospitals, to evaluate the success of a multi-faceted intervention on a scientifically sound basis."],["dc.description.sponsorship","German Ministry of Health"],["dc.identifier.doi","10.1136/ejhpharm-2021-003097"],["dc.identifier.pmid","35732426"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/117862"],["dc.identifier.url","https://publications.goettingen-research-online.de/handle/2/112129"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-581"],["dc.relatedmaterial.fulltext","https://bmjopen.bmj.com/content/bmjopen/6/8/e011908.full.pdf"],["dc.relation","Die Initiative Schlaffreundliches Krankenhaus"],["dc.relation.doi","10.1136/ejhpharm-2021-003097"],["dc.relation.eissn","2047-9964"],["dc.relation.issn","2047-9956"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights.uri","http://creativecommons.org/licenses/by-nc/4.0/"],["dc.subject.gro","benzodiazepines, Z-drugs, hospitalisation, multi-faceted intervention, quality of health care, sleep medicine"],["dc.title","Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2019Journal Article Research Paper [["dc.bibliographiccitation.firstpage","1014"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Pharmacoepidemiology and Drug Safety"],["dc.bibliographiccitation.lastpage","1022"],["dc.bibliographiccitation.volume","28"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Neukirchen, Freya"],["dc.contributor.author","Nau, Roland"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Himmel, Wolfgang"],["dc.date.accessioned","2021-08-26T11:02:39Z"],["dc.date.available","2021-08-26T11:02:39Z"],["dc.date.issued","2019"],["dc.description.abstract","To find out whether any prior experiences with sleep-inducing drugs before hospitalization and positive experiences with these drugs during hospitalization influence a patient's wish to continue taking sleep-inducing drugs after hospitalization."],["dc.identifier.doi","10.1002/pds.4806"],["dc.identifier.pmid","31179613"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16729"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88811"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.relation","Schlaf- und Beruhigungsmittel an der Schnittstelle von Krankenhaus und Hausarzt"],["dc.relation.eissn","1099-1557"],["dc.relation.issn","1053-8569"],["dc.relation.issn","1099-1557"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Patient-reported factors associated with the desire to continue taking sleep-inducing drugs after hospital discharge: A survey of older adults"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2019-12Journal Article Research Paper [["dc.bibliographiccitation.firstpage","22"],["dc.bibliographiccitation.journal","Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen"],["dc.bibliographiccitation.lastpage","31"],["dc.bibliographiccitation.volume","149"],["dc.contributor.author","Hauswaldt, Johannes"],["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Himmel, Wolfgang"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Pung, Johannes"],["dc.contributor.author","Schlegelmilch, Falk"],["dc.contributor.author","Drepper, Johannes"],["dc.date.accessioned","2020-10-29T15:25:48Z"],["dc.date.available","2020-10-29T15:25:48Z"],["dc.date.issued","2019-12"],["dc.description.abstract","The use of primary care data gathered from electronic health records in local practices could be an important building block for the future of health services research. However, the risks and reservations associated with using this data for research purposes should not be underestimated. We show the data protection and privacy problems that may arise through secondary analysis of routine primary care data and describe the technical solutions that are available to address these concerns - as a trust-building measure."],["dc.identifier.doi","10.1016/j.zefq.2020.01.002"],["dc.identifier.pmid","32165110"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68101"],["dc.language.iso","other"],["dc.relation","RADARplus - Anonymisierte Routinedaten aus der ambulanten Versorgung für die Versorgungsforschung"],["dc.relation.eissn","2212-0289"],["dc.relation.issn","1865-9217"],["dc.relation.orgunit","Institut für Medizinische Informatik"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY-NC-ND 4.0"],["dc.title","Das Risiko von Re-Identifizierung bei der Auswertung medizinischer Routinedaten – Kritische Bewertung und Lösungsansätze"],["dc.title.alternative","The risk of re-identification when analyzing electronic health records: a critical appraisal and possible solutions"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2022Journal Article [["dc.bibliographiccitation.journal","Journal of Hospital Infection"],["dc.contributor.author","Mardiko, Amelia A."],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Bludau, Anna"],["dc.contributor.author","Kaba, Hani E.J."],["dc.contributor.author","Leha, Andreas"],["dc.contributor.author","von Maltzahn, Nicole"],["dc.contributor.author","Mutters, Nico T."],["dc.contributor.author","Leistner, Rasmus"],["dc.contributor.author","Mattner, Frauke"],["dc.contributor.author","Scheithauer, Simone"],["dc.date.accessioned","2022-06-01T09:40:19Z"],["dc.date.available","2022-06-01T09:40:19Z"],["dc.date.issued","2022"],["dc.identifier.doi","10.1016/j.jhin.2022.05.012"],["dc.identifier.pii","S0195670122001633"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/108697"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-572"],["dc.relation.issn","0195-6701"],["dc.title","COVID-19 Vaccination Strategy for Hospital Staff in Germany: A Cross-Sectional Study in March-April 2021"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2022Journal Article Research Paper [["dc.bibliographiccitation.journal","Frontiers in Public Health"],["dc.bibliographiccitation.volume","10"],["dc.contributor.affiliation","Schröder, Dominik; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Heesen, Gloria; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Heinemann, Stephanie; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Hummers, Eva; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.affiliation","Jablonka, Alexandra; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Steffens, Sandra; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Mikuteit, Marie; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Niewolik, Jacqueline; 2Department of Rheumatology and Immunology, Hannover Medical School, Hanover, Germany"],["dc.contributor.affiliation","Overbeck, Tobias R.; 4Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany"],["dc.contributor.affiliation","Kallusky, Jonathan; 4Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany"],["dc.contributor.affiliation","Müller, Frank; 1Department of General Practice, University Medical Center, Göttingen, Germany"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.author","Heesen, Gloria"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Jablonka, Alexandra"],["dc.contributor.author","Steffens, Sandra"],["dc.contributor.author","Mikuteit, Marie"],["dc.contributor.author","Niewolik, Jacqueline"],["dc.contributor.author","Kallusky, Jonathan"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Overbeck, Tobias R."],["dc.date.accessioned","2022-04-26T12:34:44Z"],["dc.date.available","2022-04-26T12:34:44Z"],["dc.date.issued","2022"],["dc.date.updated","2022-05-10T16:09:22Z"],["dc.description.abstract","Background: Restrictions to contain the COVID-19 pandemic affect the social participation of people worldwide. Especially those at high risk for a severe disease tend to abstain from social gatherings. While there are a few questionnaires to measure social participation in elderly or chronic patients, a valid survey instrument that includes pandemic-related social participation is needed. Methods We developed a social participation questionnaire that aims to assess pandemic-related restrictions in social participation. Items were developed using a theory and literature-based approach and then compiled in a discursive process involving experts and lay people. This was followed by the validation of the questionnaire through a cross-sectional survey on 431 individuals. Items with low item-total correlations and low factor loadings using exploratory factor analysis [EFA] were excluded. Using EFA on the remaining items, the factor structure was retrieved and tested with a confirmatory factor analysis [CFA]. Internal consistency was assessed with Chronbachs α. Results Initially, 27 items were developed which were used for validation. 13 items were excluded due to low item-total correlations and factors loadings. EFA of the remaining 14 items revealed three factors which were identified as domains “active social participation,” “wellbeing,” and “restrictions”. CFA showed an acceptable model fit using the three-dimensional structure. Chronbachs α of 0.81 and McDonalds Ω of 0.87 indicate good internal consistency. Correlation analysis showed an association between the developed questionnaire and previously-established participation and mental health scales. Conclusion This study suggests that our 14 item questionnaire is of high reliability and validity and can be used to measure social participation during a pandemic."],["dc.identifier.doi","10.3389/fpubh.2022.831087"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/106769"],["dc.language.iso","en"],["dc.publisher","Frontiers Media S.A."],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.issn","2296-2565"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights.uri","http://creativecommons.org/licenses/by/4.0/"],["dc.title","Development and Validation of a Questionnaire to Assess Social Participation of High Risk-Adults in Germany During the COVID-19 Pandemic"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]Details DOI2022Monograph Text Edition [["dc.contributor.author","Demmer, Iris"],["dc.contributor.author","El-Sayed, Iman"],["dc.contributor.author","Heinemann, Stephanie"],["dc.contributor.author","Königs, Gloria"],["dc.contributor.author","Müller, Frank"],["dc.contributor.author","Müllenmeister, Christina"],["dc.contributor.author","Nußbaum, Kathrin"],["dc.contributor.author","Schmachtenberg, Tim"],["dc.contributor.author","Schröder, Dominik"],["dc.contributor.editor","Roder, Sascha"],["dc.contributor.editorcorporation","Sascha Roder"],["dc.date.accessioned","2022-11-07T10:03:36Z"],["dc.date.available","2022-11-07T10:03:36Z"],["dc.date.issued","2022"],["dc.identifier.isbn","978-3-00-073127-3"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/116942"],["dc.language.iso","de"],["dc.publisher","Universitätsmedizin Göttingen"],["dc.publisher.place","Göttingen"],["dc.relation","DEFEnse Against COVID-19 STudy"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.rights","CC BY 4.0"],["dc.title","(Er-)Leben mit Long COVID"],["dc.title.subtitle","Projektergebnisse einer qualitativen Studie bildhaft interpretiert"],["dc.type","book"],["dc.type.internalPublication","yes"],["dc.type.subtype","collection_book"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details